Immune thrombocytopenia (ITP) trials in Serbia
4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- Where
- Belgrade
- Age
- 18 years to 70 years
- People
- 40 worldwide
- Run by
- Kedrion S.p.A.
See details and how to joinNCT07059000 · EU 2023-507115-35-00 - Phase 2/3Taking peopleA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Where
- Belgrade, Kragujevac
- Age
- 12 years to 17 years
- People
- 24 worldwide
- Run by
- argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00 - Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- Belgrade, Kragujevac, Niš, Zemun, Zrenjanin
- Age
- 18 years and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00 - Phase 1/2Taking peopleA Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
- Where
- Belgrade, Novi Sad
- Age
- 18 years and over
- People
- 24 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07043946